P

Prime Medicine Inc
NASDAQ:PRME

Watchlist Manager
Prime Medicine Inc
NASDAQ:PRME
Watchlist
Price: 4.1 USD -3.98% Market Closed
Market Cap: 740.1m USD

Wall Street
Price Targets

PRME Price Targets Summary
Prime Medicine Inc

Wall Street analysts forecast PRME stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRME is 6.59 USD with a low forecast of 4.29 USD and a high forecast of 9.45 USD.

Lowest
Price Target
4.29 USD
5% Upside
Average
Price Target
6.59 USD
61% Upside
Highest
Price Target
9.45 USD
130% Upside
Prime Medicine Inc Competitors:
Price Targets
ADCT
ADC Therapeutics SA
93% Upside
HPHA
Heidelberg Pharma AG
63% Upside
PBYI
Puma Biotechnology Inc
19% Downside
BONEX
Bonesupport Holding AB
123% Upside
CHRS
Coherus BioSciences Inc
278% Upside
ANAB
AnaptysBio Inc
37% Upside
RXRX
Recursion Pharmaceuticals Inc
49% Upside
DTIL
Precision BioSciences Inc
564% Upside

Revenue
Forecast

Revenue Estimate
Prime Medicine Inc

For the last 4 years the compound annual growth rate for Prime Medicine Inc's revenue is -13%. The projected CAGR for the next 4 years is -6%.

-13%
Past Growth
-6%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prime Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
2%
Average Beat

Net Income
Forecast

Net Income Estimate
Prime Medicine Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-45%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRME's stock price target?
Price Target
6.59 USD

According to Wall Street analysts, the average 1-year price target for PRME is 6.59 USD with a low forecast of 4.29 USD and a high forecast of 9.45 USD.

What is Prime Medicine Inc's Revenue forecast?
Projected CAGR
-6%

For the last 4 years the compound annual growth rate for Prime Medicine Inc's revenue is -13%. The projected CAGR for the next 4 years is -6%.

Back to Top